David Young Insider Trades & Stock Holdings

Pres. Research & Development · Processa Pharmaceuticals, Inc. · Latest filing Jun 15, 2026

David Young, Pres. Research & Development at Processa Pharmaceuticals, Inc. has 2 Form 4 trades on file since Jun 15, 2026. Open-market activity: 2 purchases ($9.18K) and 0 sales ($0), net +$9.18K. Latest filing: acquired 2.07K shares of $PCSA on Jun 15, 2026 at $2.22.

Trades on file

2

Open-market bought

$9.18K

Open-market sold

$0

Net open-market

+$9.18K

Latest filing

Jun 15, 2026

All insider trades by David Young

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$PCSA	Buy (Open-market buy)	2.07K	$2.22	$4.59K			-5.9%	+8.1%		Pres. Research & Development		—
Jun 15, 2026	$PCSA	Buy (Open-market buy)	2.07K	$2.22	$4.59K			-5.9%	+8.1%		Pres. Research & Development		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks David Young traded

• $PCSA

Frequently asked questions

Has David Young been buying or selling stock?

David Young has 2 open-market purchases and 0 open-market sales on file, net +$9.18K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was David Young's latest insider trade?

acquired 2.07K shares of $PCSA on Jun 15, 2026 at $2.22.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.